chartexchange

RNA
Atrium Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
6.64USD+2.469%(+0.16)220,813
After-hoursNov 18, 2026 4:00:30 PM EST
6.64USD0.000%(0.00)
Loading…
Loading…
143.45M
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$6.48
Beta
1.13
52-Week High
$73.06 2026-02-03
52-Week Low
$6.36 2026-11-16
SMA 50
$8.32
SMA 200
$16.66
Avg. Vol 10D
208,138
Avg. Vol 30D
239,263
Avg. Vol 90D
249,214
Relative Vol
0.92
19.51M
0.5500%
1,100,000
706
RNA Profile

avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based "payloads" permit selective targeting of disease-associated mrnas against virtually any target of interest. our leadership includes seasoned scientists and executives with deep expertise in the fields of antibody conjugation, chemistry, formulations, oligonucleotide therapeutics, drug delivery and cancer biology. our employees are high energy, creative people who are passionate about solving hard problems and bringing new drugs to patients. we strive to work with partners to discover best-in-class molecules with the goal of long-term, joint value creation. we have also attracted support from top-tier investors including f-prime capital, ecor1 capital, brace pharma and other sophisticated

RNA Performance
PeriodPriceDateChangeBeta
1W7.502026-11-12-11.33%9.543
1M7.612026-10-19-12.62%0.989
3M13.712026-08-19-51.49%1.352
6M12.952026-05-19-48.65%1.215
1Y70.892025-11-19-90.62%1.129
2Y43.252024-11-19-84.62%—
5Y28.012021-11-19-76.26%-0.023
RNA Stock Summary

Atrium Therapeutics, Inc. Common Stock (NASDAQ:RNA) stock price today is $6.65, and today's volume is 220,813. RNA is up 2.623% today. The 30 day average volume is 239,263. RNA market cap is $143.45M with 21.57M shares outstanding.